Kacie L. Beatch

Kacie L. Beatch

Senior Program Manager
Cognigen

Kacie L. Beatch, Ph.D.
Senior Program Manager
Cognigen

About Kacie
Kacie joined Cognigen in May 2020 as Senior Program Manager.  She holds a Bachelor of Science degree in Clinical Laboratory Science and a PhD in Pharmaceutical Sciences from North Dakota State University.  After a two-year post-doctoral fellowship in Clinical Research, she spent seven years as a Clinical Research Scientist with focus on Phase 1 and generic drug development—contributing to over 40 product development programs and at least two dozen approved FDA submissions.  Kacie is a member of the American Association of Pharmaceutical Scientists, the American Society of Clinical Pharmacology and Therapeutics, and maintains her certification as a Medical Laboratory Scientist under the American Society of Clinical Pathology.

Latest Cognigen Research
Project Optimus –FDA’s “New” Dose Optimization & Selection Paradigm in Oncology Drug Development

Project Optimus –FDA’s “New” Dose Optimization & Selection Paradigm in Oncology Drug Development

Dr. Brian P. Booth and Dr. Hao Zhu from the Office of Clinical Pharmacology (OCP) at the FDA will present and discuss Project Optimus, an initiative from the Oncology Center of Excellence (OCE) to reform the dose optimization and dose selection paradigm in oncology drug development.

Latest Cognigen Research